Discovery of 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a Potent and Selective Inhibitor of Protein Kinase C Isotypes

被引：111

作者：

Wagner, Juergen ^{[1
]}

von Matt, Peter ^{[1
]}

Sedrani, Richard ^{[1
]}

Albert, Rainer ^{[1
]}

Cooke, Nigel ^{[1
]}

Ehrhardt, Claus ^{[1
]}

Geiser, Martin ^{[1
]}

Rummel, G'abriele ^{[1
]}

Stark, Wilhelm ^{[1
]}

Strauss, Andre ^{[1
]}

Cowan-Jacob, Sandra W. ^{[1
]}

Beerli, Christian ^{[1
]}

Weckbecker, Gisbert ^{[1
]}

Evenou, Jean-Pierre ^{[1
]}

Zenke, Gerhard ^{[1
]}

Cottens, Sylvain ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2009年 / 52卷 / 20期

关键词：

PKC-THETA;

D O I：

10.1021/jm901108b

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of novel maleimide-based inhibitors of protein kinase C (PKC) were designed, synthesized, and evaluated. AEB071 (1) was found to be a potent, selective inhibitor of classical and novel PKC isotypes. 1 is a highly efficient immunomodulator, acting via inhibition of early T cell activation. The binding mode of maleimides to PKCs, proposed by molecular modeling, was confirmed by X-ray analysis of 1 bound in the active site of PKC alpha.

引用

页码：6193 / 6196

页数：4

共 50 条

[1] 3-(1H-indol-3-yl)-4-(3,4,5-trimethoxyphenyl)-2,5-dihydro-1H-pyrrole-2,5-dione
Peifer, C
Schollmeyer, D
Dannhardt, G
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2005, 61 : O721 - O723
[2] 1-(2-Hydroxyethyl)-3-[(2-hydroxyethyl)amino]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione
Xie, Zhi-Xiong
Zhao, Sheng-Yin
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O854 - U329
[3] Discovery of (2R)-N-[3-[2-[(3-Methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propenamide (AZD4205) as a Potent and Selective Janus Kinase 1 Inhibitor
Su, Qibin
Banks, Erica
Bebernitz, Geraldine
Bell, Kirsten
Borenstein, Cassandra F.
Chen, Huawei
Chuaqui, Claudio E.
Deng, Nanhua
Ferguson, Andrew D.
Kawatkar, Sameer
Grimster, Neil P.
Ruston, Linette
Lyne, Paul D.
Read, Jon A.
Peng, Xianyou
Pei, Xiaohui
Fawell, Stephen
Tang, Zhanlei
Throner, Scott
Vasbinder, Melissa M.
Wang, Haoyu
Winter-Holt, Jon
Woessner, Richard
Wu, Allan
Yang, Wenzhan
Zinda, Michael
Kettle, Jason G.
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (09) : 4517 - 4527
[4] Anticonvulsant properties of N-(4-methylpiperazin-1-yl)- and N-[3-(4-methylpiperazin-1-yl)-propyl] derivatives of 3-aryl- and 3-spirocycloalkyl-pyrrolidine-2,5-dione
Obniska, J
Jurczyk, S
Zejc, A
Kaminski, K
Tatarczynska, E
Stachowicz, K
PHARMACOLOGICAL REPORTS, 2005, 57 (02) : 170 - 175
[5] ANTIINFLAMMATORY PROPERTIES OF THE PROTEIN-KINASE-C INHIBITOR, 3-[1-[3-(DIMETHYLAMINO)PROPYL]-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE MONOHYDROCHLORIDE (GF109203X) IN THE PMA-MOUSE EAR EDEMA MODEL
KUCHERA, S
BARTH, H
JACOBSON, P
METZ, A
SCHAECHTELE, C
SCHRIER, D
AGENTS AND ACTIONS, 1993, 39 : C169 - C173
[6] 3-(1H-Indol-3-yl)-4-(morpholin-4-yl)cyclobut-3-ene-1,2-dione
Maiwald, Franziska
Jones, Peter G.
Aref, Mahmoud
Boettcher, Marina
Karwehl, Marc
Schniers, Armin
Stanke, Carmen
Gruenefeld, Johann
MOLBANK, 2012, (02)
[7] 3,4-Bis[1-(prop-2-ynyl)-1H-indol-3-yl]1H- pyrrole-2,5-dione
Huang, Mu-Hua
Gao, Yong-Chen
Yang, Feng-Ling
Luo, Yun-Jun
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O924 - +
[8] (Z)-3-(1H-indol-3-yl)-2-(4-nitrophenyl)acrylonitrile
Qian, Bao-Hua
Liu, Wei-Wei
Hu, Hong-Wen
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2007, 63 : O3627 - U4615
[9] 3-(4-Methylpiperazin-1-yl) isobenzofuran-1(3H)-one
Odabasoglu, Mustafa
Buyukgungor, Orhan
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2008, 64 : O779 - U1202
[10] 4-[Bis(1H-indol-3-yl)methyl]benzonitrile
Deng, Xiang
Wu, Di
Huang, Xiaomei
Luo, Feihua
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O1603 - U2154

← 1 2 3 4 5 →